Engineers Gate Manager LP Takes Position in Heartflow, Inc. $HTFL

Engineers Gate Manager LP purchased a new stake in shares of Heartflow, Inc. (NASDAQ:HTFL - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 20,106 shares of the company's stock, valued at approximately $590,000.

Other hedge funds have also added to or reduced their stakes in the company. XXEC Inc. acquired a new position in Heartflow in the second quarter valued at approximately $2,524,764,000. BlackRock Inc. bought a new stake in shares of Heartflow during the 2nd quarter valued at $152,502,000. Bamco Inc. NY acquired a new position in shares of Heartflow in the 2nd quarter valued at $94,625,000. Jupiter Topco LLC bought a new position in shares of Heartflow in the 2nd quarter worth $70,983,000. Finally, Janus Henderson Group PLC boosted its position in shares of Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company's stock worth $53,063,000 after purchasing an additional 1,315,416 shares during the last quarter.

Heartflow Stock Down 0.3%

Shares of HTFL stock opened at $50.17 on Wednesday. Heartflow, Inc. has a 12 month low of $20.13 and a 12 month high of $52.22. The company's fifty day simple moving average is $38.73 and its 200-day simple moving average is $32.12. The firm has a market cap of $4.36 billion and a PE ratio of -27.42.

Heartflow (NASDAQ:HTFL - Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.22) by $0.15. The company had revenue of $64.08 million during the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business's revenue for the quarter was up 47.7% on a year-over-year basis. On average, equities analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Morgan Stanley raised their target price on Heartflow from $35.00 to $40.00 and gave the stock an "equal weight" rating in a report on Friday, August 14th. Weiss Ratings upgraded shares of Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, August 7th. Freedom Capital raised shares of Heartflow to a "strong-buy" rating in a research note on Tuesday, June 30th. UBS Group assumed coverage on shares of Heartflow in a report on Wednesday, September 9th. They set a "neutral" rating and a $55.00 price objective for the company. Finally, Wells Fargo & Company increased their target price on shares of Heartflow from $37.00 to $39.00 and gave the stock an "overweight" rating in a report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $46.25.

Insider Buying and Selling at Heartflow

In other Heartflow news, CFO Vikram Verghese sold 29,714 shares of the business's stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $50.06, for a total transaction of $1,487,482.84. Following the transaction, the chief financial officer owned 184,789 shares of the company's stock, valued at $9,250,537.34. The trade was a 13.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 19,682 shares of the company's stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $50.15, for a total value of $987,052.30. Following the sale, the insider owned 79,956 shares in the company, valued at approximately $4,009,793.40. This represents a 19.75% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 287,767 shares of company stock worth $12,871,623 over the last ninety days. 7.70% of the stock is currently owned by corporate insiders.

Heartflow Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient's coronary arteries.

The company's primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.